Underlying T2DM, inflammation, oxidative stress, and impaired insulin production and secretion among insulin resistance have been extensively studied, along with the identification of potential biomarkers that may assist in future treatment and prognostic strategies [38]. The gene discussed is INS; the disease is Insulin resistance.